Industries / Frontier science / Brain-computer interfaces
Ethics
This work covers the rules, rights and duties around devices that read or change brain activity: who may collect brain data and for what, and what happens to people when a device or its maker fails.
7
Milestones achieved, from 2020 to 2026.
2
To watch for: announced, not yet confirmed outside.
2
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
2020
Implant users left unsupported
Second Sight Medical Products stopped making its Argus II retinal implant, which gave blind people a crude kind of artificial vision, in 2019 and nearly went out of business in 2020, then turned to a brain implant called Orion. IEEE Spectrum reported in February 2022 that more than 350 people worldwide had its implants and no way to have them repaired. A 2025 systematic review in Frontiers in Neuroscience describes a similar case, "patient R", whose seizure-warning implant trial with NeuroVista ended for lack of money; she considered a second mortgage to keep the device before agreeing to switch it off and have it removed. A 2025 comment in Nature Medicine by George Kouvas and colleagues records that NeuroVista's device was trialled in 15 people and that the company's 2013 bankruptcy "led to the advised removal of all implants".
Lessonpeople come to depend on devices that only the maker can keep running, and trials rarely say what happens when the money stops.
Credit
IEEE Spectrum's reporting; the review's authors; Kouvas and colleagues
2021
Brain activity in a constitution
Chile's Law 21.383, signed by President Sebastián Piñera on 14 October 2021, added to Article 19 of the constitution that scientific and technological development must respect physical and mental integrity, and that the law must "especially protect brain activity, and the information that comes from it" (translated from Spanish).
Credit
Chile's National Congress, on a motion by senators Guido Girardi, Carolina Goic, Francisco Chahuán, Juan Antonio Coloma and Alfonso De Urresti
2023
A court halts a headset
Guido Girardi, one of the senators behind the 2021 amendment, sued Emotiv over its Insight EEG headset. The Court of Appeals rejected the case, finding nothing unlawful in Emotiv making access to the raw EEG data depend on a paid licence and acceptance of its terms. In August 2023 Chile's Supreme Court reversed that. It held that selling Insight without assessment by the health authority violated the rights to physical and mental integrity and to privacy, and ordered the health and customs authorities to study the device; BioBioChile reported that Emotiv could not sell Insight in Chile and had to delete Girardi's brain data.
Lessonaccepting a company's terms of use did not settle the matter; the court wanted a regulator to look at a consumer brain device before sale.
Credit
Chile's Supreme Court
2024
Privacy policies reviewed
The Neurorights Foundation reviewed the privacy policies and user agreements of 30 companies selling consumer neurotechnology online. By its reading, 29 of the 30 appeared to have access to users' neural data with no meaningful limits, 29 could pass data to third parties, only 12 (40%) clearly let users both withdraw consent and ask for deletion, and only 6 mentioned encryption.
Lessonthe review could judge only what the documents said, not what the companies did.
Credit
Jared Genser, Stephen Damianos and Rafael Yuste, for the Neurorights Foundation, April 2024
2024
US states protect neural data
Colorado's House Bill 24-1058, approved by the governor on 17 April 2024 and in force from 7 August 2024, added "neural data", information generated by measuring the activity of a person's central or peripheral nervous system, to the sensitive data covered by the Colorado Privacy Act. California's SB 1223, which became law as Chapter 887 on 28 September 2024, added neural data to the "sensitive personal information" of the California Consumer Privacy Act. By September 2025 Montana and Connecticut had also passed neural-data laws, according to the law firm Covington & Burling.
leg.colorado.govleginfo.legislature.ca.govcovingtonblogs.com
Credit
the Colorado General Assembly and the California Legislature
2025
A global standard adopted
UNESCO's member states adopted a Recommendation on the Ethics of Neurotechnology in November 2025, which UNESCO calls the first global normative framework on the subject; it entered into force on 12 November 2025. It advises against using neurotechnology on children for non-medical purposes, warns against using it at work to monitor productivity or profile employees, and calls for explicit consent and full transparency. The OECD Council had adopted a Recommendation on Responsible Innovation in Neurotechnology, with nine principles, on 11 December 2019, which the OECD calls "the first international standard in this domain".
Credit
UNESCO's member states; the OECD Council
2026
Headset recordings train AI
A yearlong investigation by the journal Science, reported in November 2026, found that Interaxon, maker of the Muse headband, had trained a foundation model, a large AI model meant to be adapted to many tasks, on about 50,000 hours of customers' EEG recordings before its privacy policy said so. Interaxon says names and emails are removed first. Muse's privacy policy, effective 29 September 2026, now says de-identified Muse data may be used "to train and improve our algorithms and machine-learning models (including foundation models)".
Lessona review of policy documents, like the 2024 one above, could not have caught a use the policy did not mention.
Credit
Science's reporters, as summarized by BetaNews
Watch for
A federal neural data study
The MIND Act of 2025 (Management of Individuals' Neural Data Act, S. 2925) would have the US Federal Trade Commission study how neural data is governed, where existing law leaves gaps, and what harms its misuse could cause, and update the report every year. The White House Office of Science and Technology Policy would then set out which federal uses of neurotechnology are prohibited, allowed or conditional.
Achieved whenCongress passes the bill and the FTC publishes its report. Congress.gov lists one action so far: referral to the Senate Commerce Committee on 29 September 2025.
Claimed by
Senators Chuck Schumer, Maria Cantwell and Ed Markey, September 2025
Opt-in before AI training
Emotiv's consumer health data privacy policy, effective 9 November 2026, says pseudonymized data is pooled to train its "Large Brain Model" only "subject to your explicit opt-in consent", and that Emotiv does not sell consumer health data or neural data.
Achieved whenan outside audit or a regulator confirms that recordings from users who did not opt in are kept out of the model.
Claimed by
Emotiv, November 2026
Open
01
Where headset data goes
A public table of consumer neurotechnology apps (Muse, Emotiv, Neurable and others) showing, for each, which internet hosts the app contacts during a session, how many bytes it uploads per minute of recording compared with the rate raw EEG would need, and which third-party tracking code it contains, set beside what its privacy policy says. The headset sits on a phantom head, or is not connected at all, and only traffic metadata is read, without decrypting or modifying the app.
The briefCredit · unclaimed02
A register of orphaned implants
A public register of implanted neural devices whose maker or trial sponsor has stopped, or may stop, supporting them: brain-computer interfaces, deep brain stimulators, retinal and brain visual implants and similar. For each: the device, the maker's status, the publicly reported number of people who carry it, what the maker has committed in public on repairs, spare parts and removal, and where those commitments are written. It is built only from public records, such as company filings, press releases, trial registry entries and published reports, with no individual patient information.
The briefCredit · unclaimed
Open 01 · the brief
Where headset data goes
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public table of consumer neurotechnology apps (Muse, Emotiv, Neurable and others) showing, for each, which internet hosts the app contacts during a session, how many bytes it uploads per minute of recording compared with the rate raw EEG would need, and which third-party tracking code it contains, set beside what its privacy policy says. The headset sits on a phantom head, or is not connected at all, and only traffic metadata is read, without decrypting or modifying the app.
Why it is still open
The Neurorights Foundation's 2024 report reviewed 30 companies' policy documents and correspondence, not their apps' traffic, and its authors knew of no comparable report. The 2026 Muse case shows the gap: Interaxon trained a model on users' recordings before its policy said so. A search found no study of these apps' network traffic.
Built with what exists
A spare Android phone; PCAPdroid, an app that logs a phone's connections without root access, or a router capture read in Wireshark; a static scanner for tracking code such as Exodus Privacy's; the phantom head from Wearable devices; and an AI model that reads long documents, such as Claude, to line up each policy's statements against the observed traffic, with a person checking every match. The Note "Seven more flagged" covers Claude finding issues that human reviewers missed in long documents.
First step
Install one headband's app on a spare phone, run PCAPdroid through a 10-minute session on the phantom and 10 idle minutes, and compare upload volumes.
Done looks like
At least 10 apps, each run for 3 recorded sessions and 3 idle periods; for each app, the hosts contacted, upload bytes per minute against the raw EEG rate, the trackers found, and a yes or no on whether raw EEG appears to leave the phone; published with capture summaries and a dated copy of each policy.
Open 02 · the brief
A register of orphaned implants
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public register of implanted neural devices whose maker or trial sponsor has stopped, or may stop, supporting them: brain-computer interfaces, deep brain stimulators, retinal and brain visual implants and similar. For each: the device, the maker's status, the publicly reported number of people who carry it, what the maker has committed in public on repairs, spare parts and removal, and where those commitments are written. It is built only from public records, such as company filings, press releases, trial registry entries and published reports, with no individual patient information.
Why it is still open
Work so far consists of interviews (44 researchers and trial participants in a 2022 study), a 2024 consensus definition of "neurological device abandonment" from an expert group in JAMA Network Open, and a 2025 systematic review of the ethics literature. The nearest thing to a list is a box of eight "notable examples of discontinued neural implants" in the 2025 Nature Medicine comment by Kouvas and colleagues, a one-off list without makers' commitments, which itself calls for "secure repositories" of designs and technical documents. A search found no register or tracker.
Built with what exists
ClinicalTrials.gov's public API (trial records only); SEC EDGAR company filings; FDA device databases; an AI model to pull commitments out of long filings, with a person checking and citing every field.
First step
Apply the 2024 JAMA Network Open definition to Second Sight's Argus II as the first row, then list every company-sponsored trial of an implanted neural device on ClinicalTrials.gov.
Done looks like
At least 30 devices or trials, each with a cited source on every field and the 2024 definition applied with reasons shown, published as a CSV file and a web page and updated every quarter.